Relmada Therapeutics (RLMD) Stock Chart & Stock Price History $0.35 +0.03 (+8.47%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$0.34 -0.01 (-1.63%) As of 07:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Relmada Therapeutics Stock Price Performance 5 Day Performance-45.79%1 Month Performance+15.37%3 Month Performance+0.20%6 Month Performance-89.98%Year-To-Date Performance-32.75%1 Year Performance-90.60% Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address RLMD Stock Chart for Friday, May, 2, 2025 RLMD Chart by TradingView Relmada Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$0.32$0.35+8.47%$0.38$0.322.10 million shs$11.61 million04/30/2025$0.28$0.32+13.48%$0.33$0.272.30 million shs$10.70 million04/29/2025$0.36$0.28-20.44%$0.33$0.274.68 million shs$9.43 million04/28/2025$0.65$0.36-44.64%$0.74$0.3015.43 million shs$11.85 million04/25/2025$0.74$0.65-12.51%$0.74$0.571.82 million shs$21.41 million04/24/2025$0.69$0.74+6.86%$0.75$0.545.79 million shs$24.47 million04/23/2025$0.38$0.69+82.54%$0.70$0.4133.16 million shs$22.90 million04/22/2025$0.32$0.38+17.03%$0.48$0.3215.51 million shs$12.55 million04/21/2025$0.29$0.32+11.46%$0.34$0.30796,955 shs$10.72 million04/18/2025$0.29$0.29$0.32$0.28111,991 shs$9.62 million Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$0.29$0.29-0.75%$0.32$0.28111,991 shs$9.62 million04/16/2025$0.31$0.29-5.19%$0.31$0.27138,002 shs$9.69 million04/15/2025$0.30$0.31+2.39%$0.31$0.29249,624 shs$10.22 million04/14/2025$0.30$0.30+1.79%$0.33$0.30244,258 shs$9.98 million04/11/2025$0.29$0.30+3.32%$0.30$0.27260,944 shs$9.81 million04/10/2025$0.26$0.29+10.51%$0.29$0.26262,974 shs$9.49 million04/09/2025$0.25$0.26+2.78%$0.28$0.24340,952 shs$8.59 million04/09/2025$0.25$0.26+2.78%$0.28$0.24340,952 shs$8.59 million04/08/2025$0.26$0.25-3.19%$0.26$0.25366,084 shs$8.36 million04/08/2025$0.26$0.25-3.19%$0.26$0.25366,084 shs$8.36 million04/07/2025$0.27$0.26-4.52%$0.28$0.25433,249 shs$8.63 million04/04/2025$0.28$0.27-1.27%$0.28$0.25378,196 shs$9.04 million04/03/2025$0.30$0.28-8.97%$0.33$0.28353,810 shs$8.33 million04/02/2025$0.27$0.30+10.78%$0.30$0.28509,081 shs$9.15 million04/01/2025$0.27$0.27+1.33%$0.28$0.26165,466 shs$8.26 million Related Companies Outlook Therapeutics Stock Price Chart Anebulo Pharmaceuticals Stock Price Chart Forte Biosciences Stock Price Chart VolitionRx Stock Price Chart Nabriva Therapeutics Stock Price Chart Mural Oncology Stock Price Chart Connect Biopharma Stock Price Chart Iterum Therapeutics Stock Price Chart Atara Biotherapeutics Stock Price Chart FibroBiologics Stock Price Chart Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RLMD) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RLMD Stock Free RLMD Stock Alerts